Drugs / Xiang Ju Ru Pi Ning capsule
Xiang Ju Ru Pi Ning capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06685978 | Apr 2024 → Apr 2026 overdue | hyperplasia | Tasly Pharmaceutical Group Co., Ltd | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xiang Ju Ru Pi Ning capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06685978 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Xiangjurupiling Capsule is an oral pure Chinese medicine preparation.” NCT06685978 ↗ |
| Route | Oral | “Xiangjurupiling Capsule is an oral pure Chinese medicine preparation.” NCT06685978 ↗ |